Cargando…
ROS-Sensitive Nanoparticles Co-delivering Dexamethasone and CDMP-1 for the Treatment of Osteoarthritis Through Chondrogenic Differentiation Induction and Inflammation Inhibition
Objective: Osteoarthritis (OA) is a common subtype of arthritis. To date, treatment of OA focuses primarily on alleviating pain and improving joint function. The lack of a vascular system within synovial joints and the rapid removal of agents due to synovial exchange hinder continuous delivery of OA...
Autores principales: | Wu, Xiaodong, Li, Pengpeng, Cheng, Jian, Xu, Qiang, Lu, Beiji, Han, Conghui, Huo, Weiling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876336/ https://www.ncbi.nlm.nih.gov/pubmed/33585431 http://dx.doi.org/10.3389/fbioe.2021.608150 |
Ejemplares similares
-
Icariin-Loaded Hydrogel Regulates Bone Marrow Mesenchymal Stem Cell Chondrogenic Differentiation and Promotes Cartilage Repair in Osteoarthritis
por: Zhu, Yuefeng, et al.
Publicado: (2022) -
Nanocellulose-Based Scaffolds for Chondrogenic Differentiation and Expansion
por: Szustak, Marcin, et al.
Publicado: (2021) -
Integration of Bioglass Into PHBV-Constructed Tissue-Engineered Cartilages to Improve Chondrogenic Properties of Cartilage Progenitor Cells
por: Xue, Ke, et al.
Publicado: (2022) -
Stiffness Matters: Fine-Tuned Hydrogel Elasticity Alters Chondrogenic Redifferentiation
por: Bachmann, Barbara, et al.
Publicado: (2020) -
Hybrid Bioprinting of Chondrogenically Induced Human Mesenchymal Stem Cell Spheroids
por: De Moor, Lise, et al.
Publicado: (2020)